SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-17-000062
Filing Date
2017-11-08
Accepted
2017-11-08 16:04:00
Documents
55
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 10-Q cdtx10-q2017x09.htm 10-Q 818464
2 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3112017-09.htm EX-31.1 9224
3 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3122017-09.htm EX-31.2 9191
4 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3212017-09.htm EX-32.1 6674
5 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3222017-09.htm EX-32.2 6680
  Complete submission text file 0001610618-17-000062.txt   3615648

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cdtx-20170930.xml EX-101.INS 563967
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20170930.xsd EX-101.SCH 29742
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20170930_cal.xml EX-101.CAL 49685
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20170930_def.xml EX-101.DEF 116292
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20170930_lab.xml EX-101.LAB 447454
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20170930_pre.xml EX-101.PRE 243764
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 171186555
SIC: 2836 Biological Products, (No Diagnostic Substances)